These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11308991)

  • 41. New insights into molecular mechanisms of diffuse coronary ectasiae: a possible role for VEGF.
    Savino M; Parisi Q; Biondi-Zoccai GG; Pristipino C; Cianflone D; Crea F
    Int J Cardiol; 2006 Jan; 106(3):307-12. PubMed ID: 16337037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip.
    Masuhara K; Nakai T; Yamaguchi K; Yamasaki S; Sasaguri Y
    Arthritis Rheum; 2002 Oct; 46(10):2625-31. PubMed ID: 12384920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
    Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors.
    Jinga D; Stefanescu M; Blidaru A; Condrea I; Pistol G; Matache C
    Roum Arch Microbiol Immunol; 2004; 63(3-4):141-58. PubMed ID: 17240786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteopontin and endostatin concentrations in peripheral blood of patients with adrenal tumors undergoing unilateral adrenalectomy.
    Stepien T; Jurczynska J; Lawnicka H; Stepien H; Krupinski R; Kolomecki K; Kuzdak K; Komorowski J
    Eur Surg Res; 2011; 47(3):168-72. PubMed ID: 21968021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic procedure in "incidentaloma" of the adrenal glands].
    Waldner H; Wilker D; Eibl-Eibesfeldt B
    Chirurg; 1986 Sep; 57(9):557-9. PubMed ID: 3780354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral blood concentrations of vascular endothelial growth factor and its soluble receptors (R1 and R2) in patients with adrenal cortex tumours treated by surgery.
    Jurczyńska J; Stepień T; Lawnicka H; Stepień H; Krupiński R; Kołomecki K; Kuzdak K; Komorowski J
    Endokrynol Pol; 2009; 60(1):9-13. PubMed ID: 19224499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome.
    Michizono K; Umehara F; Hashiguchi T; Arimura K; Matsuura E; Watanabe O; Fujimoto N; Okada Y; Osame M
    Neurology; 2001 Mar; 56(6):807-10. PubMed ID: 11274326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma.
    Gohji K; Fujimoto N; Komiyama T; Fujii A; Ohkawa J; Kamidono S; Nakajima M
    Cancer; 1996 Dec; 78(11):2379-87. PubMed ID: 8941010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study.
    Bülow B; Ahrén B;
    J Intern Med; 2002 Sep; 252(3):239-46. PubMed ID: 12270004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnosis and therapy of asymptomatic adrenal tumors].
    Reincke M; Winkelmann W; Jaursch-Hancke C; Kaulen D; Nieke J; Ollenschläger G; Allolio B
    Dtsch Med Wochenschr; 1989 Jun; 114(22):861-5. PubMed ID: 2721390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization.
    Daniele A; Divella R; Quaranta M; Mattioli V; Casamassima P; Paradiso A; Garrisi VM; Gadaleta CD; Gadaleta-Caldarola G; Savino E; Maci R; Bellizzi A; Fazio V
    Clin Biochem; 2014 Feb; 47(3):184-90. PubMed ID: 24355694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Long-term observations after adrenal surgery].
    Esch W; Loebenstein T
    Helv Chir Acta; 1979 Aug; 46(3):301-4. PubMed ID: 489400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.